아카소헬스 그룹(AHG) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

AHG

Akso Health Group ADR

7월 27일 4:00 PM ET (한국 7/28 05:00)

$1.46

-0.05 ▼ -3.31%

🌙 7월 27일 4:10 PM ET (한국 7/28 05:10)

$1.45

-0.01 ▼ -0.68%

아카소헬스 그룹(AHG) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$1.2B

스몰캡

P/E

배당수익률

없음

52주 위치

26%

저점 +33% · 고점 -42%

애널리스트

A-

Fundamental health

vs. Healthcare 소형주· based on 3 axes

수익성

산출 불가 (적자)

성장

Top 15%

밸류에이션

Top 15%

재무 안정

Top 29%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-0.02	Insider Own ⓘ	-	Shs Outstand ⓘ	854.0M	Perf Week ⓘ	-7.59%
Market Cap ⓘ	1.25B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	-	Shs Float ⓘ	22.9M	Perf Month ⓘ	8.96%
Enterprise Value ⓘ	1.25B	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	0.03%	Short Float ⓘ	0.17%	Perf Quarter ⓘ	-28.26%
Income ⓘ	-0.02B	P/S ⓘ	89.83	EPS this Y ⓘ	-	Inst Trans ⓘ	29.27%	Short Ratio ⓘ	0.74	Perf Half Y ⓘ	-3.31%
Sales ⓘ	0.01B	P/B ⓘ	6.91	EPS next 5Y ⓘ	-	ROA ⓘ	-8.35%	Short Interest ⓘ	0.04M	Perf YTD ⓘ	-10.98%
Book/sh ⓘ	0.21	P/C ⓘ	7334.7	EPS past 3/5Y ⓘ	24.09% 59.38%	ROE ⓘ	-9.86%	52W High ⓘ	-41.6% ($2.50)	Perf Year ⓘ	-27%
Cash/sh ⓘ	0	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	1.86% 51.13%	ROIC ⓘ	-10.36%	52W Low ⓘ	32.73% ($1.10)	Perf 3Y ⓘ	482.83%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	-679.87%	Gross Margin ⓘ	-8.39%	Volatility(W/M) ⓘ	7.71% 11.17%	Perf 5Y ⓘ	4.29%
Dividend TTM ⓘ	-	EV/Sales ⓘ	89.99	Sales Y/Y TTM ⓘ	-6.2%	Oper. Margin ⓘ	-28.93%	ATR (14) ⓘ	0.14	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	2018/8/1	Quick Ratio ⓘ	21.74	EPS Q/Q ⓘ	40.26%	Profit Margin ⓘ	-135.08%	RSI (14) ⓘ	46.6	Recom ⓘ	-
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	21.77	Sales Q/Q ⓘ	25.62%	SMA20 ⓘ	-3.71% ($1.52)	Beta ⓘ	-0.98	Target Price ⓘ	$4
Payout ⓘ	-	Debt/Eq ⓘ	0.01	Earnings ⓘ	-	SMA50 ⓘ	-1.58% ($1.48)	Rel Volume ⓘ	0.38	Prev Close ⓘ	$1.51
Employees ⓘ	12	LT Debt/Eq ⓘ	0	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-11.62% ($1.65)	Avg Volume(3M) ⓘ	0.05M	Price ⓘ	$1.46
IPO ⓘ	2017/11/3	Option/Short ⓘ	No/Yes			Trades ⓘ	76	Volume ⓘ	19,394	Change ⓘ	-3.31%

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 Akso Health Group ADR (AHG) Investment Analysis

What kind of company is Akso Health Group ADR?

아카소헬스 그룹(AHG) 방어주

Healthcare · Medical Distribution

Healthcare Stocks

Akso Health Group is a small healthcare company based in China that previously operated a social e-commerce platform before pivoting its business into the medical sector. More recently, marketing promotional services have become the core driver of its revenue, and the company has identified expanding into U.S. cancer treatment and radiation oncology services as a new growth direction. Because its business structure has been changing rapidly, the stock carries the high volatility typical of companies in transition.

Learn more about Akso Health Group ADR →

Market Cap

$1.2B

Approx. KRW 1.7 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank2478

Employees12people

IPO2017/11/03

Current Price$1.46 ≈ 2,000원

NASD · China

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🎯 Ex-div 2018년 8월 1일 (수)

Is it profitable?

Financially sound but profitability is low

Losses or thin margins — early-stage growth or weakening competitiveness

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

-28.9%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Net Margin

Share of revenue left after taxes and interest are paid

-135.1%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

-8.4%

✓ 매우 부진

My positionBottom 5%

Low range Average High range

Healthcare 소형주 Median 61.6% · Bottom tier

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

-9.9%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROA

Annual earnings relative to total company assets

-8.3%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROIC

Return generated per dollar invested in the business

-10.4%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.01

✓ Very low debt

My positionTop 25%

Low range Average High range

Healthcare 소형주 Median 0.13

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

21.77

✓ 우수

My positionTop 25%

Low range Average High range

Healthcare 소형주 Median 5.20

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

21.74

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 소형주 Median 4.80

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$4.00

현재가 대비 +174.0%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth

Mid-range within the industry

Healthy, Balanced Growth EPS and revenue are both growing steadily — a sustainable growth profile

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

+24.1%

양호

My positionMid-range

Low range Average High range

방어주 소형주 Median 16.1% · Top 37%

Past 5-Year EPS

Actual average annual EPS growth over the past 5 years

+59.4%

우수

My positionTop 5%

Low range Average High range

방어주 소형주 Median 8.7% · Top tier

Past 5-Year Revenue

How much revenue grew over the past 5 years

+51.1%

우수

My positionTop 5%

Low range Average High range

방어주 소형주 Median 6.7% · Top tier

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

+25.6%

우수

My positionTop 25%

Low range Average High range

방어주 소형주 Median 4.9% · Top 24%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -64%p below the market

AHG +4.3% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-64.1%p

Significantly behind the market

vs Health Care (XLV)

-20.2%p

behind the sector average

1-year basis

vs S&P 500

-43.0%p

Significantly behind the market

vs Health Care (XLV)

-46.7%p

Significantly behind the sector average

Current position within 52-week range

Low (-32.7%p) High (-41.6%p)

Current price is 32.7% above the 52-week low and 41.6% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-51.6%

Annualized volatility

91.9%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-27

Downtrend zone

Current price $1.46 below the midline ($1.51). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

⚡

Current diagnosis · 2026-07-27

Death cross — bearish reversal signal

MACD(0.000) crossed below Signal(0.002). Trend reversal possible; read as a sell entry point.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-27

Bearish zone

RSI 47.4 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 24.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Pricier than peers in its industry

Pricey on Vs. Assets·Vs. Sales

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

🏢 Vs. Assets Pricey

🧾 Vs. Sales Pricey

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

6.91x

✓ Pricey

My positionBottom 25%

Low range Average High range

Healthcare 소형주 median 3.17x · Bottom 22% — expensive within the industry

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

89.83x

✓ Very pricey

My positionBottom 25%

Low range Average High range

Healthcare 소형주 median 4.34x · Bottom 8% — expensive within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

Analyst target price (reference)

$4.00 vs. current price +174.0%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Healthcare 소형주

Who owns it?

Ownership flow is positive

Institutional net buying +29.3% · Short interest light 0.2%

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

No trading data for Insiders

🏦 Institutions (funds & investors)

+29.3%

Institutions large net buying

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 0.0%

Retail-led

Healthcare 소형주 Median 65.6%

👤 Retail investors (estimated) 100.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

0.2%

Low — limited short-side pressure

Healthcare 소형주 Median 11.2%

Past 90 days Little change

Short interest days to cover

0.7 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 854.0M주

Float (tradable shares) 22.9M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
AHG This Stock	$1.2B	-	6.9 ▼	-9.86% ▲	-	-3.3%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 아카소헬스 그룹(AHG)?

아카소헬스 그룹(AHG) belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is the market cap of AHG?

The market cap of AHG is approximately $1.2B, ranking 2,478 within its sector.

What is the 52-week high and low for AHG?

AHG has recorded a 52-week high of $2.50 and a low of $1.10.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.